National Health Investors, Inc (NYSE: NHI)’s stock price has plunge by 0.61relation to previous closing price of 75.31. Nevertheless, the company has seen a 5.72% surge in its stock price over the last five trading sessions. accessnewswire.com reported 2025-04-17 that MURFREESBORO, TN / ACCESS Newswire / April 17, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has rescheduled the first quarter 2025 earnings conference call and webcast starting time from 11:00 a.m. Eastern Time to 10:00 a.m.
Is It Worth Investing in National Health Investors, Inc (NYSE: NHI) Right Now?
The price-to-earnings ratio for National Health Investors, Inc (NYSE: NHI) is above average at 24.29x, Company’s 36-month beta value is 0.77.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for NHI is 44.47M, and currently, short sellers hold a 3.69% ratio of that floaft. The average trading volume of NHI on April 18, 2025 was 228.73K shares.
NHI’s Market Performance
NHI stock saw an increase of 5.72% in the past week, with a monthly gain of 0.32% and a quarterly increase of 9.40%. The volatility ratio for the week is 2.76%, and the volatility levels for the last 30 days are 3.08% for National Health Investors, Inc (NHI). The simple moving average for the past 20 days is 3.42% for NHI’s stock, with a 1.63% simple moving average for the past 200 days.
Analysts’ Opinion of NHI
Many brokerage firms have already submitted their reports for NHI stocks, with Wells Fargo repeating the rating for NHI by listing it as a “Equal Weight.” The predicted price for NHI in the upcoming period, according to Wells Fargo is $86 based on the research report published on October 01, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see NHI reach a price target of $92. The rating they have provided for NHI stocks is “Buy” according to the report published on September 24th, 2024.
BMO Capital Markets gave a rating of “Outperform” to NHI, setting the target price at $67 in the report published on March 12th of the previous year.
NHI Trading at 5.11% from the 50-Day Moving Average
After a stumble in the market that brought NHI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.03% of loss for the given period.
Volatility was left at 3.08%, however, over the last 30 days, the volatility rate increased by 2.76%, as shares surge +1.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.32% upper at present.
During the last 5 trading sessions, NHI rose by +5.72%, which changed the moving average for the period of 200-days by +12.20% in comparison to the 20-day moving average, which settled at $73.26. In addition, National Health Investors, Inc saw 9.34% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NHI starting from MCCABE ROBERT A JR, who purchase 437 shares at the price of $65.83 back on May 31 ’24. After this action, MCCABE ROBERT A JR now owns 21,585 shares of National Health Investors, Inc, valued at $28,768 using the latest closing price.
Stock Fundamentals for NHI
Current profitability levels for the company are sitting at:
- 0.63 for the present operating margin
- 0.8 for the gross margin
The net margin for National Health Investors, Inc stands at 0.41. The total capital return value is set at 0.1. Equity return is now at value 10.53, with 5.41 for asset returns.
Based on National Health Investors, Inc (NHI), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.18. The debt to equity ratio resting at 0.84. The interest coverage ratio of the stock is 7.58.
Currently, EBITDA for the company is 264.16 million with net debt to EBITDA at 4.12. When we switch over and look at the enterprise to sales, we see a ratio of 13.84. The receivables turnover for the company is 0.91for trailing twelve months and the total asset turnover is 0.13.
Conclusion
In a nutshell, National Health Investors, Inc (NHI) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
